{"title":"烟草使用障碍","authors":"O. Freudenreich","doi":"10.4135/9781483365817.n1410","DOIUrl":null,"url":null,"abstract":"The majority of patients with schizophrenia currently smokes or has smoked in the past, at much higher rates than seen in the general population. Psychiatry needs to make smoking cessation a priority and help their patients quit smoking and remain quit. In this chapter, I discuss the assessment of smoking and treatment tools for successful smoking cessation for patients with serious mental disorders. Emphasis is placed on the use of pharmacotherapy, particularly varenicline, and opt-out care, with treatment being the default option in a chronic disease model. E-cigarettes may be a harm reduction option for patients seriously addicted to cigarettes.","PeriodicalId":193490,"journal":{"name":"Psychotic Disorders","volume":"15 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Tobacco Use Disorder\",\"authors\":\"O. Freudenreich\",\"doi\":\"10.4135/9781483365817.n1410\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The majority of patients with schizophrenia currently smokes or has smoked in the past, at much higher rates than seen in the general population. Psychiatry needs to make smoking cessation a priority and help their patients quit smoking and remain quit. In this chapter, I discuss the assessment of smoking and treatment tools for successful smoking cessation for patients with serious mental disorders. Emphasis is placed on the use of pharmacotherapy, particularly varenicline, and opt-out care, with treatment being the default option in a chronic disease model. E-cigarettes may be a harm reduction option for patients seriously addicted to cigarettes.\",\"PeriodicalId\":193490,\"journal\":{\"name\":\"Psychotic Disorders\",\"volume\":\"15 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-12-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Psychotic Disorders\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4135/9781483365817.n1410\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychotic Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4135/9781483365817.n1410","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The majority of patients with schizophrenia currently smokes or has smoked in the past, at much higher rates than seen in the general population. Psychiatry needs to make smoking cessation a priority and help their patients quit smoking and remain quit. In this chapter, I discuss the assessment of smoking and treatment tools for successful smoking cessation for patients with serious mental disorders. Emphasis is placed on the use of pharmacotherapy, particularly varenicline, and opt-out care, with treatment being the default option in a chronic disease model. E-cigarettes may be a harm reduction option for patients seriously addicted to cigarettes.